Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Endoglim Trio 1.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Arkas Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Endoglim Trio 1.2mg Tablet

TriaGlimm 1.2mg tablets are classified as antidiabetic medications. This triple-action formulation treats type 2 diabetes in adults by managing blood glucose. Administer TriaGlimm 1.2mg with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking complications like kidney impairment, vision loss, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their doctor before use. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and potential blood tests (blood cell counts, liver function) are necessary as directed by your physician.

Primary Ingredients of Endoglim Trio 1.2mg Tablet

The provided text is "undefined," which has no meaning and cannot be rephrased.

Uses of Endoglim Trio 1.2mg Tablet

Managing type 2 diabetes

Major Benefits of Endoglim Trio 1.2mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Endoglim Trio 1.2mg Tablets. These tablets should be swallowed whole; do not chew, crush, or break them. Administer on an empty stomach.

Common Side effects of Endoglim Trio 1.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Endoglim Trio 1.2mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Endoglim Trio 1.2mg Tablet on an empty stomach.

How Endoglim Trio 1.2mg Tablet works:

Endoglim Trio tablets (1.2mg) contain a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Endoglim Trio 1.2mg Tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Endoglim Trio 1.2mg Tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Endoglim Trio 1.2mg Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

Endoglim Trio 1.2mg tablets pose a likely safety risk for individuals with kidney impairment and should be omitted. Medical advice is necessary. Furthermore, this medication is unsuitable for patients experiencing severe kidney dysfunction.

LiverLiverCAUTION

For individuals with liver impairment, Endoglim Trio 1.2mg Tablets require careful administration. Dosage modifications may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver disease, a low initial dose is typically prescribed; however, the medication is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Endoglim Trio 1.2mg Tablet :

Should you forget to take your Endoglim Trio 1.2mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Endoglim Trio 1.2mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Endoglim Trio 1.2mg Tablet

Endoglim Trio 1.2mg tablets contain a triple medication formulation: glimepiride, metformin, and voglibose. This medication is prescribed for managing type 2 diabetes mellitus in adults. In conjunction with a healthy diet and regular physical activity, it helps regulate blood sugar. Glimepiride stimulates insulin secretion from the pancreas to reduce blood glucose. Metformin reduces hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, decreases post-meal blood sugar levels. This combination therapy is unsuitable for type 1 diabetes.
Taking Endoglim Trio 1.2mg Tablets may cause common side effects including low blood sugar, nausea, diarrhea, changes in taste perception, gas, abdominal pain, headache, skin reactions, and respiratory infections.
Endoglim Trio 1.2mg Tablets are contraindicated in individuals with hypersensitivity to any constituent or inactive ingredient. This medication should also not be administered to patients exhibiting moderate to severe renal impairment, inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol concurrently with Endoglim Trio 1.2mg tablets is inadvisable. This combination may lead to dangerously low blood sugar and heighten the risk of lactic acidosis.
Indeed, Endoglim Trio 1.2mg Tablets may induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar can encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry readily available glucose sources, such as glucose tablets, honey, or fruit juice.
Retain this medication within its original, sealed packaging. Follow the storage guidelines printed on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Endoglim Trio 1.2mg Table...
62
MRP 76
18% off